Compare LBTYB & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LBTYB | RDNT |
|---|---|---|
| Founded | 2004 | 1985 |
| Country | Bermuda | United States |
| Employees | 6636 | N/A |
| Industry | Cable & Other Pay Television Services | Medical Specialities |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.4B |
| IPO Year | N/A | 1996 |
| Metric | LBTYB | RDNT |
|---|---|---|
| Price | $14.75 | $58.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $86.00 |
| AVG Volume (30 Days) | 5.4K | ★ 655.6K |
| Earning Date | 02-18-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,616,630,000.00 |
| Revenue This Year | $15.41 | $22.78 |
| Revenue Next Year | $1.80 | $10.70 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 13.05 |
| 52 Week Low | $9.20 | $46.76 |
| 52 Week High | $29.01 | $85.84 |
| Indicator | LBTYB | RDNT |
|---|---|---|
| Relative Strength Index (RSI) | 62.87 | 46.34 |
| Support Level | $11.60 | $51.59 |
| Resistance Level | $20.85 | $60.00 |
| Average True Range (ATR) | 0.90 | 2.11 |
| MACD | 0.11 | 0.56 |
| Stochastic Oscillator | 92.72 | 65.73 |
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.